Department of Psychology, Virginia Commonwealth University, Richmond, VA 23284, United States.
Department of Neurology, Parkinson's & Movement Disorders Center, Virginia Commonwealth University, Richmond, VA 23284, United States.
Curr Alzheimer Res. 2021;18(3):222-231. doi: 10.2174/1567205018666210608100917.
Research has documented the stigma that individuals with degenerative neurological diseases experience, but caregivers also experience stigma by association (i.e., affiliate stigma). In order to shed light on the stigma of caregivers of people with degenerative neurological diseases, the current study aimed to explore cross-cultural differences in the prevalence of Parkinson's disease (PD) caregiver affiliate stigma, as well as the relationship between PD symptoms and caregiver affiliate stigma. Applications for Alzheimer's disease are discussed.
Survey data were collected in PD clinics at public, academic medical centers. Informal caregivers of an individual with PD from the US (n = 105) and from Mexico (n = 148) participated in the study. Caregivers completed a questionnaire that included the MDS Unified PD Rating Scale to describe the symptoms of the individual with PD, as well as the Affiliate Stigma Scale and demographic information.
A series of multiple regressions was run to examine whether PD symptoms were associated with affiliate stigma and if these differed by country. These regressions suggested that different patterns of PD symptoms predicted affiliate stigma in each country. Stigma was higher in the US compared to Mexico, and the relationship between bowel/bladder symptoms and affiliate stigma was significantly stronger in the US.
Symptoms of individuals with neurodegenerative diseases are related to affiliate stigma experienced by caregivers, and these relationships may differ cross-culturally. Negative public attitudes concerning bowl and bladder issues and the physical symptoms that accompany PD remain a source of stigma for caregivers and families, particularly in the US. Interventions for caregivers of individuals with neurodegenerative diseases should include strategies for coping with stigma concerning bladder and bowel problems, as well as other physical and mental health issues.
研究记录了患有退行性神经疾病的个体所经历的污名,但照顾者也因关联而经历污名(即关联污名)。为了阐明退行性神经疾病患者照顾者的污名声誉,本研究旨在探讨帕金森病(PD)照顾者关联污名的患病率在中、美两国之间的跨文化差异,以及 PD 症状与照顾者关联污名之间的关系。对阿尔茨海默病的应用也进行了讨论。
在公共、学术医疗中心的 PD 诊所收集调查数据。来自美国(n=105)和墨西哥(n=148)的 PD 个体的非正式照顾者参加了这项研究。照顾者完成了一份问卷,其中包括 MDS 统一 PD 评定量表,以描述个体的 PD 症状,以及关联污名量表和人口统计学信息。
进行了一系列多元回归分析,以检验 PD 症状是否与关联污名有关,以及这些关系是否因国家而异。这些回归表明,不同模式的 PD 症状预测了每个国家的关联污名。与墨西哥相比,美国的污名程度更高,且在美国家庭中,肠/膀胱症状与关联污名之间的关系更为显著。
个体的神经退行性疾病症状与照顾者经历的关联污名有关,这些关系可能在跨文化上有所不同。公众对肠/膀胱问题和 PD 伴随的身体症状的负面态度仍然是照顾者和家庭的污名来源,尤其是在美国。针对神经退行性疾病患者照顾者的干预措施应包括应对与肠/膀胱问题以及其他身心健康问题相关的污名的策略。